WYMM Tour: Munich
WYMM Tour: Munich
27 February 2024, 10:00 - 16:45 CET - Munich, Germany
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Tuesday 27th February 2024 in Munich to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
10:00 – 18:00 hrs CET | Agenda (subject to change) | |
|---|---|---|
10:00 – 10:45 hrs | Registration, breakfast and networking | |
10:45 – 11:10 hrs | What you're missing matters: Catching the unnoticed | Tonya McSherry, Oxford Nanopore Technologies |
11:10 – 11:35 hrs | Rare diseases: beyond the exome | Olaf Riess, University of Tubingen |
11:35 – 12:00 hrs | Cancer methylome analysis with Oxford Nanopore Technologies - what a pathologist misses | Jürgen Hench, University Hospital Basel |
12:00 – 13:15 hrs | Lunch | |
13:15 – 13:40 hrs | Oxford Nanopore Technologies bioinformatics update | Philipp Rescheneder, Oxford Nanopore Technologies |
13:40 – 14:05 hrs | Nanopore sequencing enables detection of enhancer hijacking with allele-specific methylation | Etienne Sollier & Marvin Mayer, DKFZ |
14:05– 14:30 hrs | Nanopore sequencing applied to RNA and infection research | Redmond Smyth, Helmholtz Institute for RNA-based Infection Research |
14:30 – 15:30 hrs | Networking session | |
15:30 – 16:05 hrs | Panel discussion: The future of nanopore sequencing in clinical research | Moderated by Katrin Mansperger, Oxford Nanopore Technologies |
16:05 – 16:35 hrs | Genetic and epigenetic profiling of repeat disorders using nanopore sequencing | Morghan Lucas, Medical Genetic Center (MGZ) Munich & LMU Clinic |
16:35 – 16:45 hrs | Closing remarks | Oxford Nanopore Technologies |
16:45 – 18:00 hrs | Drinks reception |
Speakers
)
Beyond the exome
Olaf Riess, University of Tubingen
Prof Riess, MD, is full professor for Medical Genetics, director of the Institute of Medical Genetic...
)
Cancer methylome analysis with Oxford Nanopore Technologies - what a pathologist misses
Jürgen Hench, University Hospital Basel
Board-certified neuropathologist with a specific focus on molecular (neuro)pathology Working at Uni...
)
Nanopore sequencing enables detection of enhancer hijacking with allele-specific methylation
Etienne Sollier, DKFZ
I got an Engineer's degree from Ecole Polytechnique (Paris, France) and a MSc in Bioinformatics from...
)
Investigating the multimodal epigenetic landscape of Acute Myeloid Leukemia with Nanopore sequencing
Marvin Mayer, DKFZ Heidelberg
Born and rooted in Heidelberg, I am currently in the final stages of my Master's degree in Molecular...
)
Genetic and epigenetic profiling of repeat disorders using nanopore sequencing
Morghan Lucas, Medical Genetic Center (MGZ) Munich & LMU Clinic
Morghan Lucas is the co-lead of R&D at the Medical Genetics Centre (MGZ) Munich and a visiting scien...
)
Nanopore sequencing applied to RNA and infection research
Redmond Smyth, Helmholtz Institute for RNA-based Infection Research (HIRI)
Born in Ireland, Redmond studied Natural Sciences (University of Cambridge, United Kingdom), special...